Quietmind Foundation

  • Home
  • Services
    • Photobiomodulation (Light Therapy)
    • Neurofeedback
  • About
  • Clinical Trials
    • Light Therapy for Dementia
    • Vielight Clinical Trial
  • Research
  • Equipment
  • Blog

Leading Edge Commentary

COVID 19 Causes Chronic Brain Fog

8/20/2022

0 Comments

 
Picture
The Lancet has published on the persistent neurodegenerative and neuropsychiatric disorders of those with 'long COVID'. Brain fog is the most prevalent symptoms which we know is amenable to treatment with photobiomodulation and neurofeedback. 
https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(22)00260-7/fulltext#seccestitle150 
'The analysis, conducted by researchers at the University of Oxford and drawing on health records data from more than 1 million people around the world, found that while the risks of many common psychiatric disorders returned to normal within a couple of months, people remained at increased risk for dementia, epilepsy, psychosis and cognitive deficit (or brain fog) two years after contracting COVID19. Adults appeared to be at particular risk of lasting brain fog, a common complaint among coronavirus survivors.'

Neuronic Devices Ltd. and Quietmind Foundation are designing combined neurofeedback and photobiomodulation protocols to address the disrupted neural connectivity and tissue level neuropathological features of long COVID. We are working with our academic reserch partners to develop clinical trials that will provide the most scientifically reliable means for determining  the most effective PBM treatment protocols. Our research on 1070nm photobiomodulation offe useful insights as to the biological mechanisms underlying clinical improvement from long COVID. See the attached recently published paper on this topic. 

For more information on PBM for improving brain health and resistance to injury see the work being done at Prof. Paul Chazot's lab at Durham University, Quietmnidfdn.org and neuronic.online

1_rationale_for_1068_nm_photobiomodulation_therapy__pbmt__as_a_novel_non-invasive_treatment_for_covid-19_role_of_no_and_hsp70.pdf
File Size: 938 kb
File Type: pdf
Download File

0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    QMF News

    Our team regularly publishes articles and blog posts on the latest research and news coming out of our group and the field in general. 

    Archives

    February 2023
    January 2023
    December 2022
    November 2022
    October 2022
    August 2022
    July 2022
    June 2022
    April 2022
    March 2022
    February 2022
    January 2022
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    October 2019
    September 2019
    August 2019
    June 2019
    May 2019
    April 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    April 2018
    March 2018
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    May 2017

    Categories

    All
    Alzheimer's
    Biofeedback
    Breathing Training
    Dementia
    Dementia Treatment
    Drug Free Anxiety Treatment
    Infrared Light
    Light Therapy
    Neurofeedback
    Neurotherapy
    Panic Disorder
    Photobiomodulation
    Relaxation
    TBI Treatment
    Therapy

    RSS Feed

Powered by Create your own unique website with customizable templates.
  • Home
  • Services
    • Photobiomodulation (Light Therapy)
    • Neurofeedback
  • About
  • Clinical Trials
    • Light Therapy for Dementia
    • Vielight Clinical Trial
  • Research
  • Equipment
  • Blog